Sheng‐Ben Liang - Concepedia

Author

Sheng‐Ben Liang

Also Known As

Han Liang, Lemire, Mathieu, S B Liang, S. Liang, S.-B. Liang, Sheng-Ben Liang, Sheng-ben Liang, Shengben Liang, Sheng‐Ben Liang, Xiaobo Li

133

Publications

15.9K

Citations

H-Index

Concepts

All Affiliations

University of Toronto Kochi Medical School Hospital Ontario Institute for Cancer Research Princess Margaret Cancer Centre University Health Network

About

Sheng‐Ben Liang is an author at University of Toronto specializing in medicine, tumor biology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	1K
2	Cell Biology	4	4	144
3	Health Sciences	2	2	32
4	Cellular Physiology	1	1	40
5	Cellular Therapies	1	1	13

Sheng‐Ben Liang

Publications

6.4K

Citations

H-Index

Page 1

	Year	Citations
Pan-cancer analysis of whole genomes Lauri A. Aaltonen, Federico Abascal, Adam Abeshouse, Nature	2020	3.1K
Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution Michelle Chan‐Seng‐Yue, Jaeseung Kim, Gavin W. Wilson, Nature Genetics Systems BiologyTranscription PhenotypesPancreatic CancerTumor HeterogeneityGenetics	2020	644
Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS Trial Kyaw Aung, Sandra E. Fischer, Robert E. Denroche, Clinical Cancer Research	2017	613
Comprehensive molecular characterization of mitochondrial genomes in human cancers Yuan Yuan, Young Seok Ju, Young-Wook Kim, Nature Genetics	2020	489
A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns Wei Jiao, Gurnit Atwal, Paz Polak, Nature Communications	2020	230
Expression of T‐Cadherin (CDH13, H‐Cadherin) in Human Brain and Its Characteristics as a Negative Growth Regulator of Epidermal Growth Factor in Neuroblastoma Cells Tamotsu Takeuchi, Akiko Misaki, Sheng‐Ben Liang, Journal of Neurochemistry	2000	174
A Four-Chemokine Signature Is Associated with a T-cell–Inflamed Phenotype in Primary and Metastatic Pancreatic Cancer Joan Miguel Romero, Barbara T. Grünwald, Gun-Ho Jang, Clinical Cancer Research	2020	147
Divergent mutational processes distinguish hypoxic and normoxic tumours Vinayak Bhandari, Constance H. Li, Robert G. Bristow, Nature Communications	2020	141
The inhibitory anti-FGFR3 antibody, PRO-001, is cytotoxic to t(4;14) multiple myeloma cells Suzanne Trudel, A. Keith Stewart, Eran Rom, Blood	2006	140
Sex differences in oncogenic mutational processes Constance H. Li, Stephenie D. Prokopec, Ren Sun, Nature Communications	2020	122

Page 1